ProRx Recalls
14 recalls on record · September 11, 2024 to November 5, 2025 · Drugs
Recalls by year
24
25
Count of recall notices naming this brand, by the year the recall was announced. A quiet year is not proof of a safe year.
November 5, 2025DrugsFDA
ProRx LLC recalls Tirzepatide Injection, 27 mg/3 mL (9 mg/mL), 3mL Multidose Vial, For Subcutaneous Use, Rx Only, Mfd by: ProRx, 619 Jeffe
Hazard: Lack of Assurance of Sterility
November 5, 2025DrugsFDA
ProRx LLC recalls Semaglutide Injection, 5 mg/2 mL (2.5 mg/mL), 2mL Multidose Vial, For Subcutaneous Use, Rx Only, Mfd by: ProRx, 619 Jeff
Hazard: Lack of Assurance of Sterility
November 5, 2025DrugsFDA
ProRx LLC recalls Semaglutide Injection, 2.5mg/1mL (2.5 mg/mL), 1mL Multidose Vial, For Subcutaneous Use, Rx Only, Mfd by: ProRx, 619 Jeff
Hazard: Lack of Assurance of Sterility
November 5, 2025DrugsFDA
ProRx LLC recalls Semaglutide Injection, 8mg/3.2mL (2.5 mg/mL), 3.2mL Multidose Vial, For Subcutaneous Use, Rx Only, Mfd by: ProRx, 619 Je
Hazard: Lack of Assurance of Sterility
November 5, 2025DrugsFDA
ProRx LLC recalls Semaglutide Injection, 6mg/2.4mL (2.5 mg/mL), 2.4mL Multidose Vial, For Subcutaneous Use, Rx Only, Mfd by: ProRx, 619 Je
Hazard: Lack of Assurance of Sterility
November 5, 2025DrugsFDA
ProRx LLC recalls Semaglutide Injection, 10 mg/4 mL (2.5 mg/mL), 4mL Multidose Vial, For Subcutaneous Use, Rx Only, Mfd by: ProRx, 619 Jef
Hazard: Lack of Assurance of Sterility
November 5, 2025DrugsFDA
ProRx LLC recalls Semaglutide Injection, 12.5/5mL (2.5 mg/mL), 5mL Multidose Vial, For Subcutaneous Use, Rx Only, Mfd by: ProRx, 619 Jeffe
Hazard: Lack of Assurance of Sterility
September 11, 2024DrugsFDA
ProRx LLC recalls TIRZEPATIDE 60 mg/3mL (20/mg/mL), Rx Only, 3mL Multiple Dose Vial, Mfd by: ProRx Exton, PA, 19341, NDC 84139-210-02
Hazard: Lack of Assurance of Sterility
September 11, 2024DrugsFDA
ProRx LLC recalls TIRZEPATIDE 20 mg/2mL (10/mg/mL), Rx Only, 2mL Multiple Dose Vial, Mfd by: ProRx Exton, PA, 19341, NDC 84139-210-01
Hazard: Lack of Assurance of Sterility
September 11, 2024DrugsFDA
ProRx LLC recalls Semaglutide / Cyanocobalamin Injection: 2.5/0.5 mg/mL, 2 mL Multiple Dose Vial, Compounded Rx Product, ProRX 267-565-70
Hazard: Lack of Assurance of Sterility
September 11, 2024DrugsFDA
ProRx LLC recalls SEMAGLUTIDE 10mg/4mL (2.5mg/mL), 4 mL Multiple Dose Vial, Rx Only, Compounded Drug, Mfd by: ProRX Exton, PA19341, NDC 84
Hazard: Lack of Assurance of Sterility
September 11, 2024DrugsFDA
ProRx LLC recalls SEMAGLUTIDE 5mg/2mL (2.5mg/mL), Rx Only 2 mL Multiple Dose Vial, Rx Only, Compounded Drug, Mfd by: ProRX Exton, PA19341,
Hazard: Lack of Assurance of Sterility
September 11, 2024DrugsFDA
ProRx LLC recalls Tirzepatide 2 mL (10 mg/mL) and 20 mg/mL, 2mL Multidose SC Injection vials, Compounded Rx Product, ProRx 267-565-7008, N
Hazard: Lack of Assurance of Sterility
September 11, 2024DrugsFDA
ProRx LLC recalls Semaglutide, 2 mL (2.5mg/mL), Compounded RX Product, Multidose SC inj, glass vial, ProRx, 267-565-7008, NDC 84139-225-0
Hazard: Lack of Assurance of Sterility